Automatic EMG-guided botulinum toxin treatment of spasticity

Clinical Neuropharmacology

Volumn 20, Issue 3, 1997, Pages 195-203

  Finsterer, J ^a,b   Fuchs, I ^a   Mamoli, B ^a  

^a Neurological Department   (Austria)

^b NONE   (Austria)

Author keywords

Botulinum toxin therapy; Spasticity; Turn amplitude analysis

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DRUG EFFICACY; ELECTROMYOGRAM; FEMALE; HUMAN; HYPOXIA; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MULTIPLE SCLEROSIS; MUSCLE TONE; PAIN; PRIORITY JOURNAL; SPASTICITY; STROKE;

EID: 0030915555     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199706000-00002     Document Type: Article

References (27)

1. Das TK, Park TM. Botulinum toxin in treating spasticity. Br J Clin Pract 1989;43:401-3.
2. Das TK, Park TM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989;65:208-10.
3. Borg-Stein J, Pine ZM, Miller JR, Brin MF. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations. Am J Phys Med Rehabil 1993;72:364-8.
4. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-8.
5. Friedrich H, Hesse S, Mauritz KH. Botulinum-Toxin in der Therapie der Spastik. Neurol Rehabil 1992;2:178-80.
6. Hesse S, Lücke D, Malezic M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57:1321-4.
7. Koman LA, Mooney JF, Smith BP. Botulinum toxin: role in the management of cerebral palsy during childhood. In: Jankovic J. Hallet M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1993:511-22.
8. Konstanzer A, Caballos-Baumann AO, Dressnandt J, Conrad B. Local injection treatment with botulinum toxin A in severe arm and leg spasticity Nervenarzt 1993;64:517-23.
9. Memin B, Pollak P, Hommel M, Perret J. Treatment of spasticity with botulinum toxin. Rev Neurol (Paris) 1992;148:212-4.
10. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28:512-5.
11. Benecke R. Botulinum toxin for spasms and spasticity in the lower extremities. In: Jankovic J, Hallet M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1993:557-65.
12. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 1995;58:232-5.
13. Tsui JKC. Clinical trials for spasticity. In: Jankovic J, Hallet M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1993:523-33.
14. Calderon-Gonzalez R, Calderon-Sepulveda R, Rincon-Reyes M, Garcia-Ramirez J, Mino-Arango E. Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 1994;10:284-8.
15. Calne S. Local treatment of dystonia and spasticity with injections of botulinum-A toxin. Axone 1993;14: 85-8.
16. Chutorian AM, Root L. Management of spasticity in children with botulinum-A toxin. Int Pediatr 1994;9 (suppl 1):35-43.
17. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin A in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-96.
18. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45:712-7.
19. Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994; 14:299-303.
20. Koman LA, Mooney JF, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993;13:489-95.
21. Mezaki T, Kaji R, Kimura J. Botulinum toxin trial for spasticity. Rinsho Shinkeigaku 1992;32:637-8.
22. Polo KB, Jabbari B. Botulinum toxin-A improves the rigidity of progressive supranuclear palsy. Ann Neurol 1994;35:237-9.
23. Ostergaard L, Fuglsang-Frederiksen A, Werdelin L, Sjø O, Winkel H. Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study. Electroencephalogr Clin Neurophysiol 1994;93:434-9.
24. Finsterer J, Fuchs I, Mamoli B. Quantitative EMG guided botulinum toxin treatment of cervical dystonia. Clin Neuropharmacol 1997 (in press).
25. Cosgrove AP, Graham HK. Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse. Dev Med Child Neurol 1994;36:379-85.
26. Cosgrove AP, Graham HK. Botulinum toxin A in the management of children with cerebral palsy. J Bone Joint Surg [Br] 1992;74(suppl 2): 135-6.
27. Hesse S, Krajnik J, Lücke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996; 27:455-60.